---
title: "PDS Biotechnology (PDSB.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/PDSB.US/norm.md"
symbol: "PDSB.US"
name: "PDS Biotechnology"
parent: "https://longbridge.com/zh-CN/quote/PDSB.US.md"
datetime: "2026-05-21T03:25:22.453Z"
locales:
  - [en](https://longbridge.com/en/quote/PDSB.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/PDSB.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/PDSB.US/norm.md)
---

# PDS Biotechnology (PDSB.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.1324 | -0.1466 | -0.1922 | -0.2055 | -0.2095 |
| ROE | -317.73% | -323.45% | -283.61% | -196.95% | -164.17% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -7.35M | -7.56M | -9.01M | -9.43M | -8.49M |
| 营业利润 | -6.52M | -6.67M | -8.14M | -7.62M | -9.11M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | - | 30.49M | 34.71M | 40.48M | 47.03M |
| 权益乘数 | - | 3.30 | 3.67 | 2.54 | 2.10 |
| 每股净资产 | - | 0.1686 | 0.1982 | 0.3422 | 0.4921 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | - | 26.71M | 26.20M | 31.87M | 39.98M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | - | 243698.00 | 258827.00 | 273956.00 | 289085.00 |
| 净债务 | - | -9.79M | -8.23M | -13.34M | -21.02M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | - | -3.70M | -5.92M | -9.10M | -9.03M |
| 投资现金流 | - | - | - | - | - |
| 融资现金流 | - | 4.22M | 241205.00 | 995944.00 | 7.32M |
| 自由现金流 | - | -6.02M | -2.44M | -3.31M | -2.37M |
| 现金流充裕率 | - | -198.00% | -582.60% | -46.19% | -287.67% |
| 举债与偿债 | - | -1.07M | 4.00 | 19.24M | - |
| 资本支出 | - | - | - | - | - |